Qiagen NV | QIA - Ebitda

Aktienkurs
35.12
Täglich Wechseln
-0.19 -0.54%
Monatlich
-5.50%
Jährlich
-4.99%
Q2 Prognose
34.40




Ebitda Veränderung Datum
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
argenx SE USD 387.05M 99.02M 2025-09
Avita Medical AUD -9.69M 12.21M 2025-12
Dianthus Therapeutics USD -40.19M 5.36M 2025-09
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
IQVIA Holdings USD 1.05B 97M 2025-12
Moderna USD -790M 582M 2025-12
Organon & Co USD 383M 135M 2025-12
Qiagen NV USD 249.69M 56.53M 2025-12
Revvity USD 248.91M 48.52M 2025-12
Tectonic Therapeutic USD -21.18M 365K 2025-12
Viatris USD 1B 151.5M 2025-12
Xeris Pharmaceuticals USD 25.09M 7.67M 2025-12